Zacks Investment Research on MSN
Why Humana deserves patience now: Too early to buy, too risky to sell
Humana Inc. HUM has tested investor conviction over the past year as rising medical costs, reimbursement uncertainty, and ...
Humana said on Tuesday that George Renaudin will step down as president of its insurance segment and named Amazon healthcare ...
Humana trades near fair value, reflecting a mixed profit outlook and Medicare Advantage uncertainties. Click here to read an analysis of HUM stock now.
Humana's margins have declined due to rising policy benefits, high medical loss ratios, and increased utilization ...
Mark Cuban and Humana’s CEO Jim Rectin spoke about a potential partnership while speaking at the annual Forbes Healthcare Summit conference Dec. 11.
AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ...
Humana is ramping up its focus on primary care. The insurer plans to shell out between $450 million and $550 million to buy the first group of senior-focused primary care centers it built through a ...
Humana Tuesday reported $1.2 billion in 2024 profits that included a $693 million fourth quarter loss as the health insurer exits unprofitable Medicare Advantage markets for 2025, the company ...
Humana has partnered with the national Nurses on Boards Coalition (NOBC) to support nursing students through mentorship, ...
Humana's insurance segment president, George Renaudin, plans to retire next year after nearly three decades with the provider of health-insurance services. Humana on Tuesday said Renaudin will retire ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results